CD4 and viral pneumonia: Little is known about clinical and immunological outcomes of HIV-1-patients infected with SARS-CoV-2.[15] Our case report is consistent with previous researches that described progression of SARS-CoV-2 viral pneumonia in the second week of illness.[16] Furthermore, as reported in a study by Thevarajan et al,[17] peripheral CD4 and CD8 T cell count increases during host immune response, despite CD4/CD8 T cell ratio was dissimilar to the one found in the same case reported.